Chen XY - Search Results

1

Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.

Chen XY, Thike AA, Md Nasir ND, Koh VCY, Bay BH, Tan PH. Chen XY, et al. Virchows Arch. 2020 Jun;476(6):825-833. doi: 10.1007/s00428-019-02735-1. Epub 2020 Jan 3. Virchows Arch. 2020. PMID: 31897820

2

Prognostic role of immune infiltrates in breast ductal carcinoma in situ.

Chen XY, Yeong J, Thike AA, Bay BH, Tan PH. Chen XY, et al. Breast Cancer Res Treat. 2019 Aug;177(1):17-27. doi: 10.1007/s10549-019-05272-2. Epub 2019 May 27. Breast Cancer Res Treat. 2019. PMID: 31134489 Review.

3

Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer.

Goto Y, Thike AA, Ong CCH, Lim JX, Md Nasir ND, Li H, Koh VCY, Chen XY, Yeong JPS, Sasano H, Tan PH. Goto Y, et al. Among authors: chen xy. J Clin Pathol. 2020 Mar;73(3):147-153. doi: 10.1136/jclinpath-2019-206078. Epub 2019 Sep 28. J Clin Pathol. 2020. PMID: 31563883

4

Higher densities of tumour-infiltrating lymphocytes and CD4⁺ T cells predict recurrence and progression of ductal carcinoma in situ of the breast.

Thike AA, Chen X, Koh VCY, Binte Md Nasir ND, Yeong JPS, Bay BH, Tan PH. Thike AA, et al. Histopathology. 2020 May;76(6):852-864. doi: 10.1111/his.14055. Histopathology. 2020. PMID: 31883279

5

Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence.

Chen XY, Thike AA, Koh VCY, Nasir NDM, Bay BH, Tan PH. Chen XY, et al. Virchows Arch. 2021 Apr;478(4):679-686. doi: 10.1007/s00428-020-02959-6. Epub 2020 Nov 2. Virchows Arch. 2021. PMID: 33140128

6

Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence.

Tien TZ, Lee JNLW, Lim JCT, Chen XY, Thike AA, Tan PH, Yeong JPS. Tien TZ, et al. Among authors: chen xy. Histopathology. 2021 Aug;79(2):139-159. doi: 10.1111/his.14328. Epub 2021 May 6. Histopathology. 2021. PMID: 33400265 Review.

7

Therapeutic Potential of Lymphoid Infiltrates in Breast Cancer.

Chen XY, Tan PH. Chen XY, et al. Curr Med Chem. 2021;28(25):5152-5178. doi: 10.2174/0929867328666210430132701. Curr Med Chem. 2021. PMID: 33938409 Review.

8

Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review.

Chen XY, Yung LL, Tan PH, Bay BH. Chen XY, et al. Front Immunol. 2022 Mar 31;13:865554. doi: 10.3389/fimmu.2022.865554. eCollection 2022. Front Immunol. 2022. PMID: 35432376 Free PMC article. Review.

9

More microinvasive foci in larger tumours of breast ductal carcinoma in situ.

Chen XY, Thike AA, Lim JX, Bay BH, Tan PH. Chen XY, et al. Singapore Med J. 2023 Aug;64(8):493-496. doi: 10.11622/smedj.2022089. Singapore Med J. 2023. PMID: 35846408 Free PMC article.

10

Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters.

Zeng L, Koh VCY, Chen XY, Tan PH. Zeng L, et al. Among authors: chen xy. Histopathology. 2023 Apr;82(5):779-788. doi: 10.1111/his.14865. Epub 2023 Jan 30. Histopathology. 2023. PMID: 36635954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,978 results

Search Page

Filters